Brivaracetam

Overview

Brivaracetam is an anticonvulsant medication used to treat epilepsy. It is a derivative of levetiracetam with a racetam chemical structure.

API suppliers (22)

Suppliers of Brivaracetam evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• Yangzhou Aurisco Pharmaceutical Co.,Ltd.China2 active DMF
• Aurisco Pharmaceutical Co.,ltdChina1 active DMF GMP on record
• Maithri Laboratories Private LimitedIndia1 active DMF GMP on record
• LUPIN MANUFACTURING SOLUTIONS LTD1 active DMF
• Zydus Lifesciences LimitedIndia1 active DMF GMP on record
• HONOUR LAB LTDIndia1 active DMF GMP on record
• Micro Labs Usa1 active DMF
• SOLARA ACTIVE PHARMA SCIENCES LTDIndia1 active DMF GMP on record
• Shaoxing Jingxin Pharmaceutical Co., Ltd.China1 active DMF
• OPTIMUS DRUGS PRIVATE LTDIndia1 active DMF
• AMI LIFESCIENCES PRIVATE LTDIndia1 active DMF GMP on record
• BEIJING HOPE PHARMACEUTICAL CO LTD1 active DMF
• Zhejiang Huahai Pharmaceutical Co., Ltd.China1 active DMF GMP on record
• Chengda Pharmaceuticals Co., Ltd.China1 active DMF
• ALIVUS LIFE SCIENCES LTDIndia1 active DMF GMP on record
• LEE PHARMA LTDIndia1 active DMF GMP on record
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
• Divis LaboratoriesIndia1 active DMF GMP on record
• Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.China1 active DMF
• EMNAR PHARMA PRIVATE LTDIndia1 active DMF
• CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD1 active DMF GMP on record
• MAITHRI DRUGS PRIVATE LTDIndia1 active DMF GMP on record

Patent & exclusivity (US)

Per the FDA Orange Book (47 approved US products), the latest listed US patent on Brivaracetam expires 9 Apr 2030. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

5-(1,2-dihydroxyethyl)-3,4-dihydroxyoxolan-2-one

Canonical SMILES

C(C(C1C(C(C(=O)O1)O)O)O)O

InChIKey

SXZYCXMUPBBULW-UHFFFAOYSA-N

Therapeutic areas